Raymond James & Associates’s Vesper Healthcare Acquisition Corp. Unit VSPRU Stock Holding History

Raymond James & Associates’s Portfolio VSPRU Stock Details VSPRU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-16,697	Closed	-$193K	–	4298
2021 Q1	$193K	Buy	+16,697	New	+$196K	﹤0.01%	3626

Raymond James & Associates's VSPRU Position: Q2 2021 in Review

Raymond James & Associates sold out of Vesper Healthcare Acquisition Corp. Unit (VSPRU) in Q2 2021, closing a stake of 16,697 shares — an estimated $193K sold.

Raymond James & Associates first reported a position in VSPRU in Q1 2021 and held it in 1 quarter. The position peaked at $193K in Q1 2021. 0 funds tracked by Wall St. Rank hold VSPRU as of Q2 2021.

Raymond James & Associates reported no remaining Vesper Healthcare Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
Raymond James & Associates sold 16,697 Vesper Healthcare Acquisition Corp. Unit shares in Q2 2021, an estimated $193K.
Raymond James & Associates first reported a position in Vesper Healthcare Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
Raymond James & Associates's Vesper Healthcare Acquisition Corp. Unit position peaked at $193K in Q1 2021.
0 funds tracked by Wall St. Rank held Vesper Healthcare Acquisition Corp. Unit as of Q2 2021.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.